Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Diet  COVID-19 treatment studies for Diet  C19 studies: Diet  Diet   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Progression, dyspnea 25% Improvement Relative Risk Progression, fever 51% Progression, taste/smell 70% Progression, fatigue -10% Progression, cough 53% Progression, diarrhea 26% Mohajeri et al. Diet for COVID-19 Prophylaxis Is a healthy diet beneficial for COVID-19? Retrospective 600 patients in Iran Lower progression with healthier diets (p=0.00003) Mohajeri et al., Medicina, doi:10.3390/medicina59020227 Favors healthy diet Favors control
Adherence to the Mediterranean Diet Association with Serum Inflammatory Factors Stress Oxidative and Appetite in COVID-19 Patients
Mohajeri et al., Medicina, doi:10.3390/medicina59020227
Mohajeri et al., Adherence to the Mediterranean Diet Association with Serum Inflammatory Factors Stress Oxidative and Appetite.., Medicina, doi:10.3390/medicina59020227
Jan 2023   Source   PDF  
  All Studies   Meta
Retrospective 600 COVID-19 patients in Iran with moderate/severe CT scans, showing lower prevalence of dyspnea, fever, taste/smell abnormalities, and cough with high adherence to the Mediterranean diet in unadjusted results. This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of progression, 25.4% lower, RR 0.75, p < 0.001, higher quality diet 62 of 105 (59.0%), lower quality diet 392 of 495 (79.2%), NNT 5.0, dyspnea.
risk of progression, 51.1% lower, RR 0.49, p < 0.001, higher quality diet 50 of 105 (47.6%), lower quality diet 482 of 495 (97.4%), NNT 2.0, fever.
risk of progression, 70.3% lower, RR 0.30, p < 0.001, higher quality diet 23 of 105 (21.9%), lower quality diet 365 of 495 (73.7%), NNT 1.9, taste/smell.
risk of progression, 9.7% higher, RR 1.10, p = 0.03, higher quality diet 98 of 105 (93.3%), lower quality diet 421 of 495 (85.1%), fatigue.
risk of progression, 52.9% lower, RR 0.47, p < 0.001, higher quality diet 38 of 105 (36.2%), lower quality diet 380 of 495 (76.8%), NNT 2.5, cough.
risk of progression, 25.9% lower, RR 0.74, p = 0.007, higher quality diet 44 of 105 (41.9%), lower quality diet 280 of 495 (56.6%), NNT 6.8, diarrhea.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Mohajeri et al., 26 Jan 2023, retrospective, Iran, peer-reviewed, survey, 3 authors.
Contact: (corresponding author),
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperDietAll
Abstract: medicina Article Adherence to the Mediterranean Diet Association with Serum Inflammatory Factors Stress Oxidative and Appetite in COVID-19 Patients Mahsa Mohajeri 1, *, Reza Mohajery 2 1 2 3 4 * Citation: Mohajeri, M.; Mohajery, R.; Cicero, A.F.G. Adherence to the Mediterranean Diet Association with Serum Inflammatory Factors Stress Oxidative and Appetite in COVID-19 Patients. Medicina 2023, 59, 227. medicina59020227 Academic Editors: Yusra Habib Khan, and Arrigo F. G. Cicero 3,4, * Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil 56189-85991, Iran Energy Management Research Center, University of Mohaghegh Ardabili, Ardabil 56199-11367, Iran Medicine and Surgery Sciences Department, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy IRCCS AOU S. Orsola-Malpighi University Hospital, 40138 Bologna, Italy Correspondence: (M.M.); (A.F.G.C.); Tel.: +98-9143592794 (M.M.); +39-512142224 (A.F.G.C.) Abstract: Background and Objectives: The Mediterranean diet’s bioactive components are suggested to strengthen the immune system and to exert anti-inflammatory actions. This study investigated the association between adherence to the Mediterranean diet with serum inflammatory factors, total antioxidant capacity, appetite, and symptoms of COVID-19 patients. Materials and Methods: This crosssectional study was conducted among 600 Iranian COVID-19 patients selected by a simple random method. The ten-item Mediterranean diet adherence questionnaire was used to assess diet adherence. At the beginning of the study, 5 cc of blood was taken from all patients for measurement of serum interleukin 1β) IL-1β), tumor necrosis factor (TNF-α), malondialdehyde (MDA), high sensitivity Creactive protein (hs-CRP) and total antioxidant capacity (TAC). A human ELISA kit with serial number 950.090.096 produced by the Diaclone Company was used to test this cytokine using the sandwich ELISA method. Results: One hundred and five patients presented a high adherence and 495 patients presented a low adherence to the Mediterranean diet. The incidence of fever, cough, diarrhea, taste changes, and pneumonia severity index were significantly lower in patients who adhered to the Mediterranean diet more than other patients. Serum levels of tumor necrosis factor (5.7 ± 2.1 vs. 6.9 ± 2.8 p = 0.02), interleukin 1 beta (3.2 ± 0.02 vs. 4.9 ± 0.01 p = 0.02), high-sensitivity C-reactive protein (17.08 ± 4.2 vs. 19.8 ± 2.5 p = 0.03), and malondialdehyde (5.7 ± 0.2 vs. 6.2 ± 0.3 p = 0.02) were significantly lower in patients who adhered more to the Mediterranean diet than other patients. Conclusion: The Mediterranean diet can improve the symptoms and elevated serum inflammatory factors in COVID-19 patients, so clinical trial studies are suggested to confirm this effect. Tauqeer Hussain Mallhi, Tahir Mehmood Khan and Keywords: mediterranean diet; inflammatory factors; stress oxidative; appetite; COVID-19 Muhammad Salman Received: 25 December 2022 Revised: 18 January 2023 Accepted: 22 January 2023 Published: 26 January 2023 Copyright: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// 4.0/).
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop